Lymphocyte infiltrates as a prognostic variable in female breast cancer - PubMed (original) (raw)
Lymphocyte infiltrates as a prognostic variable in female breast cancer
S Aaltomaa et al. Eur J Cancer. 1992.
Abstract
The predictive value of lymphocyte infiltrates (LI) was studied in 489 patients with breast cancer followed-up for over 10 years. LI were positively correlated to axillary lymph-node status, tumour diameter and histological and morphometric variables (P less than 0.001). In a multivariate analysis LI were independently related to axillary lymph-node status. LI predicted recurrence-free survival (RFS) in rapidly proliferating tumours (P = 0.0269). LI predicted RFS (P = 0.08) and breast cancer related survival (BS) (P = 0.0164) in rapidly proliferating, axillary lymph-node negative tumours. In a multivariate analysis LI independently predicted BS (P = 0.08) in rapidly proliferating tumours. LI independently predicted BS in rapidly (P = 0.025) and slowly (P = 0.09) proliferating, axillary lymph-node negative tumours. If the tumours were not categorised according to proliferation rate, LI and outcome were not significantly related. The results clearly confirm the presence of efficient immunological antitumour defence mechanisms in human breast cancer. Consequently tumour-host interactions are subject to further studies particularly in axillary lymph-node negative breast cancer.
Similar articles
- The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjänen K. Aaltomaa S, et al. Anticancer Res. 1991 Jul-Aug;11(4):1663-9. Anticancer Res. 1991. PMID: 1746922 - Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.
Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjänen K. Aaltomaa S, et al. Int J Cancer. 1991 Dec 2;49(6):886-92. doi: 10.1002/ijc.2910490615. Int J Cancer. 1991. PMID: 1959993 - Histological assessment of the prognostic factors in female breast cancer.
Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Mari S, Alhava E, Syrjänen K. Aaltomaa S, et al. Oncology. 1992;49(1):1-8. doi: 10.1159/000227001. Oncology. 1992. PMID: 1542486 - Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G. Diel IJ, et al. J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8. doi: 10.1093/jnci/88.22.1652. J Natl Cancer Inst. 1996. PMID: 8931609 - [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Bélichard C, Faure C, Darai É, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Coutant C, Dravet F, Chauvet MP, Chéreau Ewald E, Penault-Llorca F, Goncalves A, Lambaudie É. Jauffret C, et al. Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16. Gynecol Obstet Fertil. 2015. PMID: 26482833 French.
Cited by
- Tumor infiltrating CD8+ T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma.
Mella M, Kauppila JH, Karihtala P, Lehenkari P, Jukkola-Vuorinen A, Soini Y, Auvinen P, Vaarala MH, Ronkainen H, Kauppila S, Haapasaari KM, Vuopala KS, Selander KS. Mella M, et al. Oncoimmunology. 2015 May 22;4(6):e1002726. doi: 10.1080/2162402X.2014.1002726. eCollection 2015 Jun. Oncoimmunology. 2015. PMID: 26155410 Free PMC article. - Higher CD1a Levels Correlate with PD-L1 Expression and Predict Worse Overall Survival in Triple-Negative Breast Carcinoma.
Zheng J, Wei Y, Li X, Shen Z, Zhang Y, Huang B, Jiang Y, Wang D. Zheng J, et al. Breast Care (Basel). 2022 Feb;17(1):31-39. doi: 10.1159/000513502. Epub 2021 Mar 15. Breast Care (Basel). 2022. PMID: 35355703 Free PMC article. - A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.
Greene LI, Bruno TC, Christenson JL, D'Alessandro A, Culp-Hill R, Torkko K, Borges VF, Slansky JE, Richer JK. Greene LI, et al. Mol Cancer Res. 2019 Jan;17(1):131-139. doi: 10.1158/1541-7786.MCR-18-0362. Epub 2018 Aug 24. Mol Cancer Res. 2019. PMID: 30143553 Free PMC article. - Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy.
Loi S. Loi S. Oncoimmunology. 2013 Jul 1;2(7):e24720. doi: 10.4161/onci.24720. Epub 2013 Apr 30. Oncoimmunology. 2013. PMID: 24073365 Free PMC article. - Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.
Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-Shinawi M. Mohamed MM, et al. Int J Biochem Cell Biol. 2014 Jan;46:138-47. doi: 10.1016/j.biocel.2013.11.015. Epub 2013 Nov 26. Int J Biochem Cell Biol. 2014. PMID: 24291763 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical